General Information of Drug (ID: DMKX174)

Drug Name
FOR46 Drug Info
Indication
Disease Entry ICD 11 Status REF
Multiple myeloma 2A83 Phase 1 [1]
Cross-matching ID
TTD Drug ID
DMKX174

Molecular Interaction Atlas of This Drug

Molecular Interaction Atlas

Drug Therapeutic Target (DTT)
DTT Name DTT ID UniProt ID MOA REF
Membrane cofactor protein (CD46) TTMS7DF MCP_HUMAN Not Available [2]

References

1 ClinicalTrials.gov (NCT03650491) A Study of FOR46 in Patients With Relapsed or Refractory Multiple Myeloma (RRMM). U.S. National Institutes of Health.
2 Clinical pipeline report, company report or official report of Fortis Therapeutics.